Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Argan (AGX) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Argan (AGX) over the last 14 years, with Q4 2025 value amounting to $107530.0.

  • Argan's Gains from Investment Securities fell 7982.02% to $107530.0 in Q4 2025 from the same period last year, while for Oct 2025 it was $107530.0, marking a year-over-year decrease of 7982.02%. This contributed to the annual value of $583337.0 for FY2025, which is 5726.47% down from last year.
  • As of Q4 2025, Argan's Gains from Investment Securities stood at $107530.0, which was down 7982.02% from $95977.0 recorded in Q3 2025.
  • Argan's Gains from Investment Securities' 5-year high stood at $19.7 million during Q1 2025, with a 5-year trough of $9000.0 in Q2 2022.
  • Over the past 5 years, Argan's median Gains from Investment Securities value was $1.4 million (recorded in 2022), while the average stood at $3.1 million.
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first tumbled by 9974.43% in 2022, then soared by 1566666.67% in 2023.
  • Quarter analysis of 5 years shows Argan's Gains from Investment Securities stood at $1.4 million in 2021, then increased by 1.74% to $1.4 million in 2022, then crashed by 97.93% to $29058.0 in 2023, then surged by 1733.78% to $532860.0 in 2024, then crashed by 79.82% to $107530.0 in 2025.
  • Its Gains from Investment Securities stands at $107530.0 for Q4 2025, versus $95977.0 for Q3 2025 and $1.6 million for Q2 2025.